Christina Henson to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Christina Henson has written about Xenograft Model Antitumor Assays.
Connection Strength
0.044
-
Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer. Sci Rep. 2022 01 19; 12(1):974.
Score: 0.044
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.